A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: pharmacokinetic and pharmacodynamic rationale for dosing.

Source:http://linkedlifedata.com/resource/pubmed/id/17289894

Clin. Cancer Res. 2007 Feb 1 13 3 986-93

Download in:

View as

Triples

General Info

PMID
17289894